Biomarkers for bipolar disorder: current insights

References

• Malhi GS, Fritz K, Allwang C, et al. Agitation for recognition by DSM-5 mixed features specifier signals fatigue? Aust N Z J Psychiatry. 2015;49(6):499–501.
   Web of Science ®Google Scholar
• Frey BN, Andreazza AC, Houenou J, et al. Biomarkers in bipolar disorder: a positional paper from the international society for bipolar disorders biomarkers task force. Aust N Z J Psychiatry. 2013;47(4):321–332.
   PubMed Web of Science ®Google Scholar
• Scola G, Andreazza AC. Current state of biomarkers in bipolar disorder. Curr Psychiatry Rep. 2014;16(12):514. doi: 10.1007/s11920-014-0514-4.
   PubMed Web of Science ®Google Scholar
• Scola G, Andreazza AC. The role of neurotrophins in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2015;56:122–128.
   PubMed Web of Science ®Google Scholar
• Keck PE Jr, Kessler RC, Ross R. Clinical and economic effects of unrecognized or inadequately treated bipolar disorder. J Psychiatr Pract. 2008;14 Suppl 2:31–38.
   Google Scholar
• Bandettini PA. What’s new in neuroimaging methods? Ann N Y Acad Sci. 2009;1156:260–293.
   PubMed Web of Science ®Google Scholar
• Hariri AR, Bookheimer SY, Mazziotta JC. Modulating emotional responses: effects of a neocortical network on the limbic system. Neuroreport. 2000;11(1):43–48.
   PubMed Web of Science ®Google Scholar
• Brooks JO 3rd, Vizueta N. Diagnostic and clinical implications of functional neuroimaging in bipolar disorder. J Psychiatr Res. 2014;57:12–25.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Bartzokis G, Grieder T, et al. An MRI study of temporal lobe structures in men with bipolar disorder or schizophrenia. Biol Psychiatry. 2000;48(2):147–162.
   Web of Science ®Google Scholar
• Lopez-Larson MP, DelBello MP, Zimmerman ME, Schwiers ML, Strakowski SM. Regional prefrontal gray and white matter abnormalities in bipolar disorder. Biol Psychiatry. 2002;52(2):93–100.
   Web of Science ®Google Scholar
• Blumberg HP, Kaufman J, Martin A, et al. Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder. Arch Gen Psychiatry. 2003;60(12):1201–1208.
   Web of Science ®Google Scholar
• Keener MT, Phillips ML. Neuroimaging in bipolar disorder: a critical review of current findings. Curr Psychiatry Rep. 2007;9(6):512–520.
   Google Scholar
• Phillips ML, Swartz HA. A critical appraisal of neuroimaging studies of bipolar disorder: toward a new conceptualization of underlying neural circuitry and a road map for future research. Am J Psychiatry. 2014;171(8):829–843.
   PubMed Web of Science ®Google Scholar
• Brambilla P, Bellani M, Yeh PH, Soares JC, Tansella M. White matter connectivity in bipolar disorder. Int Rev Psychiatry. 2009;21(4):380–386.
   PubMed Web of Science ®Google Scholar
• Versace A, Andreazza AC, Young LT, et al. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol Psychiatry. 2014;19(2):200–208.
   PubMed Web of Science ®Google Scholar
• Dupont RM, Jernigan TL, Gillin JC, Butters N, Delis DC, Hesselink JR. Subcortical signal hyperintensities in bipolar patients detected by MRI. Psychiatry Res. 1987;21(4):357–358.
   Web of Science ®Google Scholar
• Stoll AL, Renshaw PF, Yurgelun-Todd DA, Cohen BM. Neuroimaging in bipolar disorder: what have we learned? Biol Psychiatry. 2000;48(6):505–517.
   Web of Science ®Google Scholar
• Kempton MJ, Geddes JR, Ettinger U, Williams SC, Grasby PM. Meta-analysis, database, and meta-regression of 98 structural imaging studies in bipolar disorder. Arch Gen Psychiatry. 2008;65(9):1017–1032.
   PubMed Web of Science ®Google Scholar
• Altshuler LL, Curran JG, Hauser P, Mintz J, Denicoff K, Post R. T2 hyperintensities in bipolar disorder: magnetic resonance imaging comparison and literature meta-analysis. Am J Psychiatry. 1995;152(8):1139–1144.
   PubMed Web of Science ®Google Scholar
• Vataja R, Pohjasvaara T, Leppavuori A, et al. Magnetic resonance imaging correlates of depression after ischemic stroke. Arch Gen Psychiatry. 2001;58(10):925–931.
   PubMed Web of Science ®Google Scholar
• Gootjes L, Teipel SJ, Zebuhr Y, et al. Regional distribution of white matter hyperintensities in vascular dementia, alzheimer’s disease and healthy aging. Dement Geriatr Cogn Disord. 2004;18(2):180–188.
   Web of Science ®Google Scholar
• Beaulieu C. The basis of anisotropic water diffusion in the nervous system – a technical review. NMR Biomed. 2002;15(7–8):435–455.
   PubMed Web of Science ®Google Scholar
• Vederine FE, Wessa M, Leboyer M, Houenou J. A meta-analysis of whole-brain diffusion tensor imaging studies in bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2011;35(8):1820–1826.
   PubMed Web of Science ®Google Scholar
• Heng S, Song AW, Sim K. White matter abnormalities in bipolar disorder: Insights from diffusion tensor imaging studies. J Neural Transm. 2010;117(5):639–654.
   PubMed Web of Science ®Google Scholar
• Kafantaris V, Kingsley P, Ardekani B, et al. Lower orbital frontal white matter integrity in adolescents with bipolar I disorder. J Am Acad Child Adolesc Psychiatry. 2009;48(1):79–86.
   PubMed Web of Science ®Google Scholar
• McIntosh AM, Munoz Maniega S, Lymer GK, et al. White matter tractography in bipolar disorder and schizophrenia. Biol Psychiatry. 2008;64(12):1088–1092.
   PubMed Web of Science ®Google Scholar
• Mahon K, Burdick KE, Szeszko PR. A role for white matter abnormalities in the pathophysiology of bipolar disorder. Neurosci Biobehav Rev. 2010;34(4):533–554.
   PubMed Web of Science ®Google Scholar
• Macritchie KA, Lloyd AJ, Bastin ME, et al. White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry. 2010; 196(1):52–58.
   PubMed Web of Science ®Google Scholar
• Haznedar MM, Roversi F, Pallanti S, et al. Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses. Biol Psychiatry. 2005;57(7):733–742. doi: 10.1016/j.biopsych.2005.01.002.
   PubMed Web of Science ®Google Scholar
• Houenou J, Wessa M, Douaud G, et al. Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry. 2007;12(11):1001–1010.
   Web of Science ®Google Scholar
• Versace A, Almeida JR, Hassel S, et al. Elevated left and reduced right orbitomedial prefrontal fractional anisotropy in adults with bipolar disorder revealed by tract-based spatial statistics. Arch Gen Psychiatry. 2008;65(9):1041–1052.
   PubMed Web of Science ®Google Scholar
• Wessa M, Houenou J, Leboyer M, et al. Microstructural white matter changes in euthymic bipolar patients: a whole-brain diffusion tensor imaging study. Bipolar Disord. 2009;11(5):504–514.
   PubMed Web of Science ®Google Scholar
• Yurgelun-Todd DA, Silveri MM, Gruber SA, Rohan ML, Pimentel PJ. White matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study. Bipolar Disord. 2007;9(5):504–512.
   Web of Science ®Google Scholar
• Torgerson CM, Irimia A, Leow AD, et al. DTI tractography and white matter fiber tract characteristics in euthymic bipolar I patients and healthy control subjects. Brain Imaging Behav. 2013;7(2):129–139.
   Web of Science ®Google Scholar
• Chaddock CA, Barker GJ, Marshall N, et al. White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br J Psychiatry. 2009;194(6):527–534.
   PubMed Web of Science ®Google Scholar
• Russo SJ, Nestler EJ. The brain reward circuitry in mood disorders. Nat Rev Neurosci. 2013;14(9):609–625. doi: 10.1038/nrn3381; 10.1038/nrn3381.
   PubMed Web of Science ®Google Scholar
• Urosevic S, Abramson LY, Harmon-Jones E, Alloy LB. Dysregulation of the behavioral approach system (BAS) in bipolar spectrum disorders: review of theory and evidence. Clin Psychol Rev. 2008;28(7):1188–1205. doi: 10.1016/j.cpr.2008.04.004; 10.1016/j.cpr.2008.04.004.
   PubMed Web of Science ®Google Scholar
• Alloy LB, Abramson LY. The role of the behavioral approach system (BAS) in bipolar spectrum disorders. Curr Dir Psychol Sci. 2010;19(3):189–194. doi: 10.1177/0963721410370292.
   PubMed Web of Science ®Google Scholar
• Johnson SL. Mania and dysregulation in goal pursuit: a review. Clin Psychol Rev. 2005;25(2):241–262. doi: 10.1016/j.cpr.2004.11.002.
   PubMed Web of Science ®Google Scholar
• Singh T, Rajput M. Misdiagnosis of bipolar disorder. Psychiatry (Edgmont). 2006;3(10):57–63.
   Google Scholar
• Haber SN, Knutson B. The reward circuit: linking primate anatomy and human imaging. Neuropsychopharmacology. 2010;35(1):4–26.
   PubMed Web of Science ®Google Scholar
• Nusslock R, Young CB, Damme KS. Elevated reward-related neural activation as a unique biological marker of bipolar disorder: assessment and treatment implications. Behav Res Ther. 2014;62:74–87. doi: 10.1016/j.brat.2014.08.011; 10.1016/j.brat.2014.08.011.
   Web of Science ®Google Scholar
• Bermpohl F, Kahnt T, Dalanay U, et al. Altered representation of expected value in the orbitofrontal cortex in mania. Hum Brain Mapp. 2010;31(7):958–969. doi: 10.1002/hbm.20909; 10.1002/hbm.20909.
   PubMed Web of Science ®Google Scholar
• Harmon-Jones E, Abramson LY, Nusslock R, et al. Effect of bipolar disorder on left frontal cortical responses to goals differing in valence and task difficulty. Biol Psychiatry. 2008;63(7):693–698. doi: 10.1016/j.biopsych.2007.08.004.
   Web of Science ®Google Scholar
• Mason L, O’Sullivan N, Bentall RP, El-Deredy W. Better than I thought: positive evaluation bias in hypomania. PLoS One. 2012;7(10):e47754. doi: 10.1371/journal.pone.0047754; 10.1371/journal.pone.0047754.
   Web of Science ®Google Scholar
• Satterthwaite TD, Kable JW, Vandekar L, et al. Common and dissociable dysfunction of the reward system in bipolar and unipolar depression. Neuropsychopharmacology. 2015;40(9):2258–2268.
   PubMed Web of Science ®Google Scholar
• Thibodeau R, Jorgensen RS, Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J Abnorm Psychol. 2006;115(4):715–729. doi: 10.1037/0021-843X.115.4.715.
   PubMed Web of Science ®Google Scholar
• Foti D, Hajcak G. Depression and reduced sensitivity to non-rewards versus rewards: evidence from event-related potentials. Biol Psychol. 2009;81(1):1–8. doi: 10.1016/j.biopsycho.2008.12.004; 10.1016/j.biopsycho.2008.12.004.
   PubMed Web of Science ®Google Scholar
• Grimm O, Heinz A, Walter H, et al. Striatal response to reward anticipation: evidence for a systems-level intermediate phenotype for schizophrenia. JAMA Psychiatry. 2014;71(5):531–539.
   Web of Science ®Google Scholar
• Schloesser RJ, Huang J, Klein PS, Manji HK. Cellular plasticity cascades in the pathophysiology and treatment of bipolar disorder. Neuropsychopharmacology. 2008;33(1):110–133. doi: 10.1038/sj.npp.1301575.
   PubMed Web of Science ®Google Scholar
• Drevets WC. Neuroimaging studies of mood disorders. Biol Psychiatry. 2000;48(8):813–829.
   PubMed Web of Science ®Google Scholar
• Post RM. Kindling and sensitization as models for affective episode recurrence, cyclicity, and tolerance phenomena. Neurosci Biobehav Rev. 2007;31(6):858–873. doi: 10.1016/j.neubiorev.2007.04.003.
   PubMed Web of Science ®Google Scholar
• Savitz JB, Price JL, Drevets WC. Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network. Neurosci Biobehav Rev. 2014;42:132–147. doi: 10.1016/j.neubiorev.2014.02.008; 10.1016/j.neubiorev.2014.02.008.
   PubMed Web of Science ®Google Scholar
• Kato T, Shioiri T, Murashita J, Hamakawa H, Inubushi T, Takahashi S. Phosphorus-31 magnetic resonance spectroscopy and ventricular enlargement in bipolar disorder. Psychiatry Res. 1994;55(1):41–50.
   Web of Science ®Google Scholar
• Nasrallah HA, McCalley-Whitters M, Jacoby CG. Cortical atrophy in schizophrenia and mania: a comparative CT study. J Clin Psychiatry. 1982;43(11):439–441.
   Web of Science ®Google Scholar
• Pearlson GD, Garbacz DJ, Tompkins RH, et al. Clinical correlates of lateral ventricular enlargement in bipolar affective disorder. Am J Psychiatry. 1984;141(2):253–256.
   Web of Science ®Google Scholar
• Strakowski SM, DelBello MP, Zimmerman ME, et al. Ventricular and periventricular structural volumes in first- versus multiple-episode bipolar disorder. Am J Psychiatry. 2002;159(11):1841–1847.
   Web of Science ®Google Scholar
• Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK. Lithium-induced increase in human brain grey matter. Lancet. 2000;356(9237):1241–1242.
   PubMed Web of Science ®Google Scholar
• Sassi RB, Nicoletti M, Brambilla P, et al. Increased gray matter volume in lithium-treated bipolar disorder patients. Neurosci Lett. 2002;329(2):243–245.
   Web of Science ®Google Scholar
• Bearden CE, Thompson PM, Dalwani M, et al. Greater cortical gray matter density in lithium-treated patients with bipolar disorder. Biol Psychiatry. 2007;62(1):7–16. doi: 10.1016/j.biopsych.2006.10.027.
   PubMed Web of Science ®Google Scholar
• Ongur D, Drevets WC, Price JL. Glial reduction in the subgenual prefrontal cortex in mood disorders. Proc Natl Acad Sci U S A. 1998;95(22):13290–13295.
   PubMed Web of Science ®Google Scholar
• Rajkowska G, Halaris A, Selemon LD. Reductions in neuronal and glial density characterize the dorsolateral prefrontal cortex in bipolar disorder. Biol Psychiatry. 2001;49(9):741–752.
   PubMed Web of Science ®Google Scholar
• Benes FM, Vincent SL, Todtenkopf M. The density of pyramidal and nonpyramidal neurons in anterior cingulate cortex of schizophrenic and bipolar subjects. Biol Psychiatry. 2001;50(6):395–406.
   Web of Science ®Google Scholar
• Rajkowska G. Postmortem studies in mood disorders indicate altered numbers of neurons and glial cells. Biol Psychiatry. 2000;48(8):766–777.
   PubMed Web of Science ®Google Scholar
• Cotter D, Mackay D, Chana G, Beasley C, Landau S, Everall IP. Reduced neuronal size and glial cell density in area 9 of the dorsolateral prefrontal cortex in subjects with major depressive disorder. Cereb Cortex. 2002;12(4):386–394.
   PubMed Web of Science ®Google Scholar
• Psychiatric GWAS Consortium Bipolar Disorder Working Group. Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4. Nat Genet. 2011;43(10):977–983.
   PubMed Web of Science ®Google Scholar
• Bowley MP, Drevets WC, Ongur D, Price JL. Low glial numbers in the amygdala in major depressive disorder. Biol Psychiatry. 2002;52(5):404–412.
   Web of Science ®Google Scholar
• Machado-Vieira R, Andreazza AC, Viale CI, et al. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci Lett. 2007;421(1):33–36.
   PubMed Web of Science ®Google Scholar
• Dean B, Gray L, Scarr E. Regionally specific changes in levels of cortical S100beta in bipolar 1 disorder but not schizophrenia. Aust N Z J Psychiatry. 2006;40(3):217–224. doi: 10.1111/j.1440-1614.2006.01777.x.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Sacher J, Steiner J, Schoenknecht P, Mueller K. Serum S100B represents a new biomarker for mood disorders. Curr Drug Targets. 2013;14(11):1237–1248.
   PubMed Web of Science ®Google Scholar
• Schroeter ML, Abdul-Khaliq H, Sacher J, Steiner J, Blasig IE, Mueller K. Mood disorders are glial disorders: evidence from in vivo studies. Cardiovasc Psychiatry Neurol. 2010;2010:780645. doi: 10.1155/2010/780645; 10.1155/2010/780645.
   Google Scholar
• Berk M, Dodd S, Kauer-Sant’anna M, et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand Suppl. 2007;(434)(434):41–49. doi: 10.1111/j.1600-0447.2007.01058.x.
   Google Scholar
• de Bartolomeis A, Buonaguro EF, Iasevoli F, Tomasetti C. The emerging role of dopamine-glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: implications for treatment. J Psychopharmacol. 2014;28(6):505–526. doi: 10.1177/0269881114523864.
   PubMed Web of Science ®Google Scholar
• Rao JS, Kellom M, Reese EA, Rapoport SI, Kim HW. Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients. J Affect Disord. 2012;136(1–2):63–71. doi: 10.1016/j.jad.2011.08.017; 10.1016/j.jad.2011.08.017.
   Web of Science ®Google Scholar
• Anand A, Barkay G, Dzemidzic M, et al. Striatal dopamine transporter availability in unmedicated bipolar disorder. Bipolar Disord. 2011;13(4):406–413. doi: 10.1111/j.1399-5618.2011.00936.x; 10.1111/j.1399-5618.2011.00936.x.
   Web of Science ®Google Scholar
• Stork C, Renshaw PF. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol Psychiatry. 2005;10(10):900–919.
   PubMed Web of Science ®Google Scholar
• Yildiz-Yesiloglu A, Ankerst DP. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings. Prog Neuropsychopharmacol Biol Psychiatry. 2006;30(6):969–995. doi: 10.1016/j.pnpbp.2006.03.012.
   Web of Science ®Google Scholar
• Frye MA, Watzl J, Banakar S, et al. Increased anterior cingulate/medial prefrontal cortical glutamate and creatine in bipolar depression. Neuropsychopharmacology. 2007;32(12):2490–2499.
   PubMed Web of Science ®Google Scholar
• Ongur D, Jensen JE, Prescot AP, et al. Abnormal glutamatergic neurotransmission and neuronal-glial interactions in acute mania. Biol Psychiatry. 2008;64(8):718–726.
   PubMed Web of Science ®Google Scholar
• Dager SR, Friedman SD, Parow A, et al. Brain metabolic alterations in medication-free patients with bipolar disorder. Arch Gen Psychiatry. 2004;61(5):450–458.
   PubMed Web of Science ®Google Scholar
• Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry. 2000;47(4):305–313.
   PubMed Web of Science ®Google Scholar
• Eastwood SL, Harrison PJ. Markers of glutamate synaptic transmission and plasticity are increased in the anterior cingulate cortex in bipolar disorder. Biol Psychiatry. 2010;67(11):1010–1016. doi: 10.1016/j.biopsych.2009.12.004; 10.1016/j.biopsych.2009.12.004.
   PubMed Web of Science ®Google Scholar
• Shibuya-Tayoshi S, Tayoshi S, Sumitani S, Ueno S, Harada M, Ohmori T. Lithium effects on brain glutamatergic and GABAergic systems of healthy volunteers as measured by proton magnetic resonance spectroscopy. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(1):249–256. doi: 10.1016/j.pnpbp.2007.08.015.
   Web of Science ®Google Scholar
• International Schizophrenia Consortium, Purcell SM, Wray NR, et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460(7256):748–752. doi: 10.1038/nature08185; 10.1038/nature08185.
   PubMed Web of Science ®Google Scholar
• Craddock N, Sklar P. Genetics of bipolar disorder. Lancet. 2013; 381(9878):1654–1662. doi: 10.1016/S0140-6736(13)60855-7; 10.1016/S0140-6736(13)60855-7.
   PubMed Web of Science ®Google Scholar
• Maletic V, Raison C. Integrated neurobiology of bipolar disorder. Front Psychiatry. 2014;5:98. doi: 10.3389/fpsyt.2014.00098; 10.3389/fpsyt.2014.00098.
   PubMed Web of Science ®Google Scholar
• Nurnberger JI Jr, Koller DL, Jung J, et al. Identification of pathways for bipolar disorder: a meta-analysis. JAMA Psychiatry. 2014;71(6):657–664. doi: 10.1001/jamapsychiatry.2014.176; 10.1001/jamapsychiatry.2014.176.
   Web of Science ®Google Scholar
• Bhat S, Dao DT, Terrillion CE, et al. CACNA1C (Cav1.2) in the pathophysiology of psychiatric disease. Prog Neurobiol. 2012;99(1):1–14. doi: 10.1016/j.pneurobio.2012.06.001; 10.1016/j.pneurobio.2012.06.001.
   Web of Science ®Google Scholar
• Vacher H, Mohapatra DP, Trimmer JS. Localization and targeting of voltage-dependent ion channels in mammalian central neurons. Physiol Rev. 2008;88(4):1407–1447. doi: 10.1152/physrev.00002.2008; 10.1152/physrev.00002.2008.
   PubMed Web of Science ®Google Scholar
• Soeiro-de-Souza MG, Bio DS, Dias VV, Vieta E, Machado-Vieira R, Moreno RA. The CACNA1C risk allele selectively impacts on executive function in bipolar type I disorder. Acta Psychiatr Scand. 2013;128(5):362–369. doi: 10.1111/acps.12073; 10.1111/acps. 12073.
   PubMedGoogle Scholar
• Ruberto G, Vassos E, Lewis CM, et al. The cognitive impact of the ANK3 risk variant for bipolar disorder: initial evidence of selectivity to signal detection during sustained attention. PLoS One. 2011;6(1):e16671. doi: 10.1371/journal.pone.0016671; 10.1371/journal.pone.0016671.
   Web of Science ®Google Scholar
• Cichon S, Muhleisen TW, Degenhardt FA, et al. Genome-wide association study identifies genetic variation in neurocan as a susceptibility factor for bipolar disorder. Am J Hum Genet. 2011;88(3):372–381. doi: 10.1016/j.ajhg.2011.01.017; 10.1016/j.ajhg.2011.01.017.
   Web of Science ®Google Scholar
• Tiwary BK. The severity of mental disorders is linked to interaction among candidate genes. Integr Biol (Camb). 2012;4(9):1096–1101. doi: 10.1039/c2ib20066j; 10.1039/c2ib20066j.
   Web of Science ®Google Scholar
• Sodersten K, Palsson E, Ishima T, et al. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: a study of two independent cohorts. J Affect Disord. 2014;160:1–9. doi: 10.1016/j.jad.2014.01.009; 10.1016/j.jad.2014.01.009.
   PubMed Web of Science ®Google Scholar
• Green EK, Raybould R, Macgregor S, et al. Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case-control study of over 3000 individuals from the UK. Br J Psychiatry. 2006;188:21–25. doi: 10.1192/bjp.bp.105.009969.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Borkowska A, Skibinska M, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci. 2006;60(1):70–76. doi: 10.1111/j.1440-1819.2006.01462.x.
   Web of Science ®Google Scholar
• Vincze I, Perroud N, Buresi C, et al. Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disord. 2008;10(5):580–587. doi: 10.1111/j.1399-5618.2008.00603.x; 10.1111/j.1399-5618.2008.00603.x.
   PubMed Web of Science ®Google Scholar
• Rotondo A, Mazzanti C, Dell’Osso L, et al. Catechol o-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry. 2002;159(1):23–29.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Suwalska A, Czerski PM, Dmitrzak-Weglarz M, Leszczynska-Rodziewicz A, Hauser J. Prophylactic effect of lithium in bipolar affective illness may be related to serotonin transporter genotype. Pharmacol Rep. 2005;57(1):124–127.
   Web of Science ®Google Scholar
• Ferreira Ade A, Neves FS, da Rocha FF, et al. The role of 5-HTTLPR polymorphism in antidepressant-associated mania in bipolar disorder. J Affect Disord. 2009;112(1–3):267–272. doi: 10.1016/j.jad.2008.04.012; 10.1016/j.jad.2008.04.012.
   Web of Science ®Google Scholar
• Geaghan M, Cairns MJ. MicroRNA and posttranscriptional dysregulation in psychiatry. Biol Psychiatry. 2015;78(4):231–239.
   Web of Science ®Google Scholar
• Sun E, Shi Y. MicroRNAs: small molecules with big roles in neurodevelopment and diseases. Exp Neurol. 2015;268:46–53.
   PubMed Web of Science ®Google Scholar
• Forero DA, van der Ven K, Callaerts P, Del-Favero J. miRNA genes and the brain: implications for psychiatric disorders. Hum Mutat. 2010; 31(11):1195–1204.
   PubMed Web of Science ®Google Scholar
• Kim J, Bartel DP. Allelic imbalance sequencing reveals that single-nucleotide polymorphisms frequently alter microRNA-directed repression. Nat Biotechnol. 2009;27(5):472–477.
   Web of Science ®Google Scholar
• Kim AH, Reimers M, Maher B, et al. MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res. 2010;124(1–3):183–191.
   PubMed Web of Science ®Google Scholar
• Moreau MP, Bruse SE, David-Rus R, Buyske S, Brzustowicz LM. Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder. Biol Psychiatry. 2011;69(2):188–193.
   PubMed Web of Science ®Google Scholar
• Wang X, Wang X. Systematic identification of microRNA functions by combining target prediction and expression profiling. Nucleic Acids Res. 2006;34(5):1646–1652.
   Web of Science ®Google Scholar
• Lim LP, Lau NC, Garrett-Engele P, et al. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature. 2005;433(7027):769–773.
   PubMed Web of Science ®Google Scholar
• Wang Z, Zhang C, Huang J, et al. MiRNA-206 and BDNF genes interacted in bipolar I disorder. J Affect Disord. 2014;162:116–119.
   PubMed Web of Science ®Google Scholar
• Cheng LC, Pastrana E, Tavazoie M, Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat Neurosci. 2009;12(4):399–408.
   PubMed Web of Science ®Google Scholar
• Yoo AS, Staahl BT, Chen L, Crabtree GR. MicroRNA-mediated switching of chromatin-remodelling complexes in neural development. Nature. 2009;460(7255):642–646.
   PubMed Web of Science ®Google Scholar
• Rajasethupathy P, Fiumara F, Sheridan R, et al. Characterization of small RNAs in aplysia reveals a role for miR-124 in constraining synaptic plasticity through CREB. Neuron. 2009;63(6):803–817.
   PubMed Web of Science ®Google Scholar
• Shih WL, Kao CF, Chuang LC, Kuo PH. Incorporating information of microRNAs into pathway analysis in a genome-wide association study of bipolar disorder. Front Genet. 2012;3:293.
   Google Scholar
• Zhou R, Yuan P, Wang Y, et al. Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers. Neuropsychopharmacology. 2009;34(6):1395–1405.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Convertini P, Shen M, et al. Valproic acid causes proteasomal degradation of DICER and influences miRNA expression. PLoS One. 2013;8(12):e82895.
   PubMed Web of Science ®Google Scholar
• Rong H, Liu TB, Yang KJ, et al. MicroRNA-134 plasma levels before and after treatment for bipolar mania. J Psychiatr Res. 2011;45(1):92–95.
   PubMed Web of Science ®Google Scholar
• Ben-Shachar D. The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia. J Neural Transm. 2009;116(11):1383–1396.
   Web of Science ®Google Scholar
• Scola G, Kim HK, Young LT, Andreazza AC. A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry. 2013;73(2):e4–e5.
   PubMed Web of Science ®Google Scholar
• Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res. 2010;68(4):261–275.
   PubMed Web of Science ®Google Scholar
• Xing M. Oxidative stress: A new risk factor for thyroid cancer. Endocr Relat Cancer. 2012;19(1):C7–C11.
   Web of Science ®Google Scholar
• Wang JF, Shao L, Sun X, Young LT. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009;11(5):523–529.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Shao L, Wang JF, Young LT. Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry. 2010;67(4):360–368.
   PubMed Web of Science ®Google Scholar
• Che Y, Wang JF, Shao L, Young T. Oxidative damage to RNA but not DNA in the hippocampus of patients with major mental illness. J Psychiatry Neurosci. 2010;35(5):296–302.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Wang JF, Salmasi F, Shao L, Young LT. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J Neurochem. 2013;127(4):552–561.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kauer-Sant’anna M, Frey BN, et al. Oxidative stress markers in bipolar disorder: a meta-analysis. J Affect Disord. 2008; 111(2–3):135–144.
   PubMed Web of Science ®Google Scholar
• Andreazza AC, Kapczinski F, Kauer-Sant’Anna M, et al. 3-nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder. J Psychiatry Neurosci. 2009;34(4):263–271.
   PubMed Web of Science ®Google Scholar
• Brown NC, Andreazza AC, Young LT. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014; 218(1–2):61–68.
   PubMed Web of Science ®Google Scholar
• Kim HK, Chen W, Andreazza AC. The potential role of the NLRP3 inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder. Neural Plast. 2015; 2015:408136.
   Web of Science ®Google Scholar
• Munkholm K, Brauner JV, Kessing LV, Vinberg M. Cytokines in bipolar disorder vs healthy control subjects: a systematic review and meta-analysis. J Psychiatr Res. 2013;47(9):1119–1133.
   PubMed Web of Science ®Google Scholar
• Goldstein BI, Fagiolini A, Houck P, Kupfer DJ. Cardiovascular disease and hypertension among adults with bipolar I disorder in the united states. Bipolar Disord. 2009;11(6):657–662.
   Web of Science ®Google Scholar
• Drexhage RC, Knijff EM, Padmos RC, et al. The mononuclear phagocyte system and its cytokine inflammatory networks in schizophrenia and bipolar disorder. Expert Rev Neurother. 2010;10(1):59–76.
   PubMed Web of Science ®Google Scholar
• Hope S, Dieset I, Agartz I, et al. Affective symptoms are associated with markers of inflammation and immune activation in bipolar disorders but not in schizophrenia. J Psychiatr Res. 2011;45(12):1608–1616.
   PubMed Web of Science ®Google Scholar
• Acheson A, Conover JC, Fandl JP, et al. A BDNF autocrine loop in adult sensory neurons prevents cell death. Nature. 1995;374(6521):450–453.
   PubMed Web of Science ®Google Scholar